A spinal root avulsion injury disconnects spinal roots with the spinal cord. The rampant motoneuron death, inhibitory CNS/PNS transitional zone (TZ) for axonal regrowth and limited regeneration speed together lead to motor dysfunction. Microtubules rearrange to assemble a new growth cone and disorganized microtubules underline regeneration failure. It has been shown that microtubule-stabilizing drug, Epothilone B, enhanced axonal regeneration and attenuated fibrotic scaring after spinal cord injury. Here, we are reporting that after spinal root avulsion+ re-implantation in adult rats, EpoB treatment improved motor functional recovery and potentiated electrical responses of motor units. It facilitated axons to cross the TZ and promoted more and bigger axons in the peripheral nerve. Neuromuscular junctions were reformed with better preserved postsynaptic structure, and muscle atrophy was prevented by EpoB administration. Our study showed that EpoB was a promising therapy for promoting axonal regeneration after peripheral nerve injury.
Introduction
Spinal root avulsion is a clinically relevant injury where high power mechanical stretch is applied, leading to rupture of the spinal roots at the emerging site from the spinal cord (Leffert, 1985; Carlstedt, 2007; Carlsedt, 2008) . The injury damages the affected spinal root and the associated spinal cord as well. The close proximity of the lesion to the cell body leads to rampant progressive motoneuron death (Chai et al., 1999; Inciong et al., 2000; Hoang et al., 2003) . New axons can form from preexisting dendrites or from the cell body directly (Linda et al., 1985) . However, they often take meandering courses in the inhibitory CNS/PNS transitional zone (TZ) and some of them end up with retraction bulb (Cajal, 1928; Fraher, 2000) . In addition, the limited intrinsic axonal regeneration speed and the long length they have to go through before they can reinnervate their target muscles together result into chronic denervation of distal muscles and eventually motor dysfunction (Sakuma et al., 2016) . Surgical re-implantation of the avulsed roots to the spinal cord can improve the survival rate of injured motoneuron (Gu et al., 2004) , but it is not enough to achieve efficient regeneration and satisfactory functional recovery.
As one of the major cytoskeleton components, microtubule participants in all critical axonal processes, including the formation of growth cone, axonal growth and regeneration, as well as axonal transportations (Conde & Caceres, 2009; Kalil & Dent, 2014; Kapitein & Hoogenraad, 2015; Kevenaar & Hoogenraad, 2015) . It is composed of tubulin heterodimers aligning in a head-to-tail style, which give rise to the polarity of microtubules (Kapitein & Hoogenraad, 2015) . It is dynamically instable, continuously undergoing cycles of polymerization and depolymerization. After an axotomy, both actin and microtubule rearrange to assemble a new growth cone for regeneration (Bradke et al., 2012) . Bundles of parallel microtubules are located in the center of the growth cone, and their net polymerization and elongation lead to axonal extension. Retraction bulbs, hallmark of regeneration failure, are featured with disorganized microtubules (Bradke et al., 2012; Hur et al., 2012) . Disturbing the bundling structure of microtubules transformed growth cones into retraction-bulblike structures (Erturk et al., 2007) .
Microtubule stabilization (MS; Cheng et al., 2008) reagents are a group of chemicals that target tubulins and promote polymerization (Hur et al., 2012) . Indeed, treatment of taxol, one MS drug, enabled both CNS and PNS axons to grow cross the inhibitory environment in vitro (Erturk et al., 2007; Brizuela et al., 2015) . Systemic administration of taxol after spinal cord injury not only promoted axonal regeneration through the lesion site but also reduced scarring via influencing the transforming growth factor-b pathway (Hellal et al., 2011) . Similarly, Epothiline B (EpoB), another MS chemical, also showed dual effects of enhanced axonal regrowth and attenuated fibrotic scarring after spinal cord injury (Ruschel et al., 2015) . More importantly, the blood-brain barrier permeable property of EpoB makes it clinically applicable for axonal regeneration.
Here, we asked whether microtubule stabilization by EpoB could enhance motor axonal regeneration and promote motor functional restoration after a spinal root avulsion injury. We induced cervical ventral root avulsion+ re-implantation in adult rats before systematically treating them with EpoB or vehicle control. We observed remarkably improved motor functional recovery in the EpoB-treated animals. Administration of EpoB not only facilitated more motor axons to grow across the CNS/PNS TZ and into the peripheral nerve trajectory but also showed neuroprotection. These axons formed synaptic contact with distal muscle fibers and muscle atrophy was reduced. Our study confirmed EpoB as a promising therapeutic strategy for promoting axonal regeneration after peripheral nerve injury.
Methods and materials

Animals
Adult female Sprague-Dawley rats (275-305 g, 70-90 days) were ordered from the Laboratory Animal Unit of the University of Hong Kong. All animal caring and surgery procedures were approved by the Committee for Use of Live Animals in Teaching and Research of the university. All experiments were carried out in accordance with the approved protocol.
Surgery
The surgery was performed as previously described (Su et al., 2013) . A cocktail of ketamine (80 mg/kg of body weight) and xylazine (8 mg/kg of body weight) was injected intraperitoneally to anesthetize the animals. The lower cervical spine was exposed, and the right vertebral lamina of C4-C7 was removed and the dura opened laterally. Transection of the C5-C7 dorsal roots was performed for better manipulation of corresponding ventral roots. The avulsion of the three ventral roots was made via a fine glass hook. The avulsed C6 ventral root was immediately reattached back to the ventrolateral pia surface of the spinal cord, while the C5 and C7 ventral and dorsal roots were cut and removed to prevent regeneration. Muscles and the skin were closed separately. Every 15 minutes during the surgery, the body temperature, heart rate, respiration rate and Saturated Pulse Oxygenation (SpO 2 ) were checked to ensure the normal body function of the animals, and the toe reflex was examined to confirm that animals were under proper anesthesia. All these processes were recorded and submitted to the Committee for Use of Live Animals in Teaching and Research of the university. Whenever needed in surgery, one-third of the original dosage of anesthesia was applied. Lidocaine was applied for local anesthesia before manipulating the spinal root.
Preparation of EpoB
EpoB was purchased from Selleckchem (catalog no. s1364). Due to its poor solubility of in water, the 25 mg pack powder of EpoB was dissolved in 333 lL DMSO (Sigma, D2650) and stocked at the concentration of 75 mg/mL. For injection, high concentration of EpoB was diluted with water into 0.75 mg/mL.
Treatment and grouping
Animals were randomly divided into two groups and treated with EpoB or vehicle. At 1-and 15-day post-surgery, EpoB was injected intraperitoneally at a dosage of 0.75 mg/kg body weight (n = 10). At the same time points, comparable volume of saline was also injected intraperitoneally as vehicle control (n = 11). Animals were kept for 9 weeks except for those used for electromyography (EMG), which were killed at 6-week post-surgery. At the animal endpoint, lethal dosage of sodium pentobarbitone (150 mg/kg) was injected intraperitoneally. Animals were then intracardially perfused with saline, followed with 4% paraformaldehyde for fixation. The C4-C8 spinal cord together with the associated right C6 spinal root, the musculocutaneous nerve and the biceps of both sides were dissected out and processed for dehydration in 30% sucrose for 2 days. All the tissues were preserved for further analysis as detailed below.
Behavioral test
The Terzis grooming test (TGT; Bertelli & Mira, 1993; Inciong et al., 2000) was adopted to evaluate the motor function of upper limbs. About 5 mL of water was sprayed onto the head and snout of the testing rat, which would induce grooming reaction of the upper limbs. A rating system was briefly described as follows: 0, no response; 1, flexion at elbow, not reaching the snout; 2, flexion reaching the snout; 3, reaching below the eyes; 4, reaching to the eyes; 5, reaching to the ears and beyond. At 24-hour post-surgery, TGT was conducted to confirm the success of surgery and all animals scared 0. Starting from the 3rd week after surgery, all animals were subjected to weekly TGT till the endpoint. Data were expressed as mean + SEM, and MannWhitney U test was adopted as statistical analysis.
Electromyography (EMG)
At 6 weeks after surgery, needle EMG was performed by using an RM6240 multichannel signal process system (Chengdu Instrument Factory, Chengdu, China), as described previously (Li et al., 2015) . Two representative animals from each group were anesthetized by intraperitoneally injecting a mixture of ketamine (80 mg/kg of body weight) and xylazine (8 mg/kg body weight). The musculocutaneous nerve and biceps of both left and right side were exposed. The nerve was hooked onto the curved stimulation electrode, while the two recording electrodes, with a distance of 5 mm, were inserted into the corresponding biceps, at a depth of 1-2 mm. To detect spontaneous potential at resting, five different sites from each muscle were elected and recorded for 2 minutes. At the same sites, a serial of voltage stimulations (0.1 V, 0.5 V, 1.0 V, 1.5 V, 2.0 V, duration of 2 ms, each repeat five times, 2-second interval) were applied and the responding amplitudes recorded.
Retrograde labeling and quantifying of labeled cells
At 9-week post-surgery, two representative animals were selected from each group for retrograde labeling. After anesthesia by intraperitoneal injection of a mixture of ketamine (80 mg/kg of body weight) and xylazine (8 mg/kg of body weight), the musculocutaneous nerve was exposed. About 0.5 lL FluoroGold (FG; Fluorochrome, 6% in sterilized water) was slowly injected into the nerve via a fine glass capillary. Four days after injection, animals were euthanized by overdose of sodium pentobarbitone (150 mg/kg), followed with intracardial perfusion with saline and then with 4% paraformaldehyde for fixation. Spinal cord segments C4-C8 were dissected and dehydrated in 30% sucrose for 2 days. After being imbedded in optimal cutting temperature (compound), frozen sections of the ventral spinal cord were cut longitudinally at the thickness of 20 lm. All sections were collected for further analysis. Fluorescence microscope (Nikon M-11) with a 420-nm filter was used for observation, and images were digitized by SPOT RT camera for record. On every second sections, labeled cells with clear nucleus in the segments of C5-C7 were counted and summed up. The averaged numbers of labeled cells of each group were calculated.
Quantitation of motor axons in the CNS/PNS TZ and surviving motoneurons in the ventral spinal cord
Fixed spinal cord C4-C8 was sectioned longitudinally at the thickness of 20 lm. Every four sections were utilized for ChAT immunostaining. The sections were first treated with 10 lg/mL proteinase K at 37°C for 10 min, to expose the antigens. ChAT antibody (Millipore, 1 : 100) was incubated overnight at 4°C, followed with a secondary antibody (Invitrogen, 1 : 400, conjugated to AlexaFluor 488) for 1.5 h. At the CNS/PNS TZ where reimplantation took place, four images were digitized from each animal. The angle distribution of ChAT+ axons was measured and their total number counted by IMAGEJ. The averaged number of ChAT+ axons of vehicle group was regarded as 1, and the relative numbers of all the tested animals were calculated and presented. In the spinal cord gray matter, the ChAT+ cells with dark nucleus and diameter more than 30 lm were regarded as surviving motoneurons. The number of motoneurons in the C5-C6 spinal cord was counted manually. Five animals from each group were used for these two assessments. Chi-square test was used to test the statistical significance. Observation and digitization were carried out under the fluorescence microscope Olympus BX51.
Immunostaining of CSPG and GFAP
Spinal cord sections were incubated with CS-56 antibody (Sigma, C8035, 1 : 200) or GFAP antibody (Sigma, G9269, 1 : 500) overnight at 4°C, followed with a secondary antibody (Invitrogen, 1 : 400, conjugated to AlexaFluor 568) for 1.5 h. Three animals from each group were elected for immunostaining of these two antibodies. For CS-56 stained sections, four images from each animal were taken under the fluorescence microscope Olympus BX51 and the fluorescence intensity was measured using IMAGEJ. Student's t test was applied to test the significance.
Measurement of motor axons in the peripheral nerve
Cross sections of the musculocutaneous nerve were made at two sites: the proximal end and 2 mm proximal to its entrance to the biceps. Sections were stained with ChAT antibody as above described. n = 5 for each group. The numbers of ChAT+ axons from every assessed animal were counted manually under the fluorescence microscope Olympus BX51 and presented in the dot plot. Data were analyzed by one-way analysis of means.
Assessment of axon diameters and electron microscopy
The most distal part (2 mm of length) of musculocutaneous nerve before it went into biceps was collected and processed for electron microscopy (EM). The nerve segments were fixed overnight with a cocktail of 2% PFA and 2.5% glutaraldehyde in 0.1 M PB. It was followed with post-fixation with 1% osmium tetroxide overnight. Dehydration was performed by graded ethanol (30%, 50%, 70%, 80%, 90%, 95% for 5 min each and 100% for three times in 30 min). Infiltration was conducted by putting the tissues into an order of chemicals: propylene oxide (PO) (twice, 15 min each), PO: Epon (1 : 1, 1 h), pure Epon (overnight). The nerves were then embedded in Epon and polymerized at 60°C for 72 h. Semithin sections (0.5 lm thickness) were cut and stained with 0.5% toluidine blue in 1% borax. Observation and digitization were conducted under the microscope Nikon MM-11. n = 3 for contralateral side, n = 5 for ipsilateral side of both EpoB and vehicle treated groups. Images were taken and at least 40 axons from each animal were randomly selected to measure the area, using IMAGEJ. The corresponding diameter was calculated. Data were expressed in boxplot, with the maximum, 3rd quartile, median, 1st quartile and minimum data points marked. z test was applied to test significance. Ultrathin sections were cut at the thickness of 60 nm and stained with 3% uranyl acetate. Images were captured by transmission EM (Phillip model, 208).
Hematoxylin and eosin (H&E) staining and quantitation of muscle fiber diameters
Biceps were sectioned at a thickness of 14 lm. Every four sections were used for H&E staining. Nuclei were stained with Harris hematoxylin for 8-10 min and differentiated with 0.3% acid alcohol. Sarcoplasm was stained with eosin for 2 min. The sections were dehydrated by graded ethanol (75%, 95% and 100%). Microscope Nikon MM-11 was utilized for observation, and 8-10 images were randomly taken from each section. The diameters of muscle fibers were measured by IMAGEJ. n = 5 for each group. Statistical analysis of the data was performed by z test.
Examination of motor endplates (MEPs)
Every four sections of biceps were used for ChAT staining as described before. After incubation with secondary antibody, the sections were stained with a-bungarotoxin (a-BTX, Invitrogen, Alexa Fluor 594 conjugated, 1 : 500) for 30 min. Fluorescence microscope Olympus BX51 was used for observation. 10-15 MEP were randomly selected from each section for imaging and the areas were measured with IMAGEJ. n = 5 for each group. Data were analyzed with z test.
Data analysis
Data expression and methods of hypothesis testing were described separately in Methods and materials section. All statistical analysis and plotting were performed by R.
Results
EpoB treatment promoted motor functional recovery
Clinically, a brachial plexus injury leads to sensorimotor dysfunction of the affected upper limb. Our animal model mimics the extreme case of upper brachial plexus injury by avulsing the 5th, 6th and 7th cervical roots. This consequently caused immediate denervation of most upper limb muscles, including biceps, deltoid, brachialis and brachioradialis (Ali et al., 2015) . With surgical re-implantation of C6 ventral root, animals regained some motor functions gradually (Gu et al., 2004) . Terzis Grooming test (Bertelli & Mira, 1993; Inciong et al., 2000) has been adopted to evaluate the motor function of upper limb after brachial plexus injury. At 24-h post-surgery, all animals were subjected to TGT and scored 0, indicating loss of grooming function. Although functional recovery started within 3 weeks after the surgery in both EpoB-and vehicle-treated groups, EpoB administration remarkably increased the averaged TGT score (Fig. 1a ). Significant differences between the two groups were observed from the 3rd week till the end of survival period (9-week post-surgery) (P < 0.05, Mann-Whitney U test). In addition, more than 60% of EpoB-treated animals achieved the highest 5 score at 9-week post-surgery, whereas less than 20% of vehicle animals recovered to the comparable level (Fig. 1b) .
EpoB treatment potentiated EMG responses
Excitable motoneurons transmit and convey their orders to muscle fibers via electrical signals. We, therefore, performed needle EMG to test the electrical conduction and responses in motor units (Brown et al., 2002) . Denervated muscle fibers overexpress acetylcholine receptors (AchRs) on the whole membrane surface, instead of clustered in the postsynaptic fold of neuromuscular junction as observed in normal muscle fibers (Mills, 2005) . The overwhelming AchRs give rise to hypersensitivity of muscle fibers and they spontaneously discharge when resting. Any lower motoneuron lesion can give rise to fibrillation, a form of spontaneous potential. As reinervation progresses, spontaneous potential disappears gradually. With the maturation of motor unit, the amplitude of response increases (Brown et al., 2002) .
We first measured the frequency of fibrillations. No fibrillations were detected in the intact contralateral muscles, but they existed in the ipsilateral biceps of both treatment groups (Fig. 2a) . Notably, EpoB treatment reduced the firing rate of fibrillations, which might be attributed to fewer denervated muscle fibers. Second, we evoked the nerve with different voltage stimulations. We found that above the threshold, the same volume of voltage triggered higher amplitude in EpoB-treated muscles and the maximum electrical reaction evoked was increased by EpoB treatment (Fig. 2b) . In addition, the recorded waves display typical triphasic configuration (Fig. 2c) . These observations suggested more matured motor units in EpoB-administrated animals.
EpoB treatment showed neuroprotection
As the survival of injured motoneurons is essential for regeneration, we therefore asked whether increased surviving motoneurons contributed to the improved motor function and electrophysiology of EpoB animals. We first performed retrograde labeling by injecting FG into the musculocutaneous nerve and quantified the number of FG labeled cells in the ventral spinal cord. Seventy-two percent more motoneurons were labeled in EpoB animals compared with the vehicle animals ( Fig. 3a and Table 1 ), reflecting that more motoneurons in EpoB animals have regrown their axons to the distal peripheral nerve. Meanwhile, higher FG intensity was detected in EpoB-treated motoneurons (Fig. 3a) , which may underlie a higher efficiency of axonal transportation.
We next used choline acetyltransferase (ChAT) as a marker (Hoang et al., 2003; Ohlsson et al., 2013) to assess the number of surviving motoneurons in the affected ipsilateral ventral spinal cord (C5-C7). Following an axotomy, the ChAT expression undergo drastic downregulation in surviving motoneurons and the low ChAT level can stay for as long as 4 weeks (Kou et al., 1995; Rende et al., 1995; Chang et al., 2004) . After that, ChAT expression goes back to detectable level. At 9-week post-surgery, 38% more ChAT+ cells were counted in the EpoB-treated animals than that of the vehicle-treated animals ( Fig. 3b and c, P < 0.001, chi-square test). The increase of surviving motoneurons (38%) was slightly lower than that of FG-labeled cells (72%) (Table 1), which probably suggested that higher percentage of surviving motoneurons in EpoB-treated animals has regenerated their axons to musculocutaneous nerve. In addition to the increased motoneurons, more ChAT+ neurites were observed in the gray matter of EopB spinal cord (Fig. 3c) , which may underlie more complex dendritic tree and more communication with other neurons.
EpoB treatment enabled more and directional axon elongation in CNS/PNS transitional zone High amount of astrocytes is located in the glia limitans at the CNS/ PNS TZ, and their processes form a thick layer to enclose single myelinated nerve fibers (Fraher, 2000) . Following the avulsion injury, these astrocytes are activated and release inhibitory chondroitin sulfate proteoglycans (CSPG) into the environment, making the CNS/PNS TZ a barrier for motor axonal regeneration. We evaluated the capability of motor axons to navigate through the interface by measuring the number of ChAT+ axons successfully extended into the re-implanted ventral root. Nine weeks after re-implantation, the avulsed ventral root formed firm physical connection with the spinal cord and a lot of motor axons regrew to the reattached interface, which was accompanied with angiogenesis ( Fig. 4a) . EpoB application facilitated 39% more axons to successfully grow into the reattached ventral root (Fig. 4a-c , P < 0.001, chi-square test). The higher amount of motor axons in TZ might underlie plenty of collateral branching. In addition, EpoB treatment promoted directional axonal elongation. Vehicle axons randomly made a lot of turns in the TZ, giving raise to their evenly distributed angle (from À90 to 90, refer to Fig. 4d) , regardless of from which direction the ventral root was attached. In contrary, EpoB greatly abolished the meandering elongation. Instead, EpoB enabled axons to extend more directly into the re-implanted root, generating a more clustered angle distribution ( Fig. 4b and d) .
Reasonably, we asked whether the directional axonal elongation in EpoB animals can be attributed to the attenuated impediment in the CNS/PNS TZ. Animals with systematic EpoB administration showed remarkable CSPG deduction, compared with the intense CSPG expression in vehicle-treated animals, even at 9 weeks after the surgery (Fig. 5a and b, **P < 0.01, Student's t test). The high CSPG level was not just restricted in the CNS/PNS TZ, but also distributed in the lesioned ventral root. The alleviated CSPG expression was not due to suppressed activation of astrocytes, as reflected by the comparable GFAP intensity in TZ of the two animal groups (Fig. 5c ). It can be inferred that the activation and protective sealing of astrocytes were not altered when they decreased the release of CSPG.
EpoB treatment increased the number of ChAT+ axons in peripheral nerve
Consistent with the increased number of axons in TZ, more motor axons were found in the peripheral nerve trajectory in EpoB-administrated animals. At both the proximal and distal end of musculocutaneous nerve, ChAT-positive axons were more than doubled by EpoB invention (Fig. 6 , P < 0.001, one-way analysis of means). As the axons extended distally along the peripheral nerve, the difference of axon number between the two groups enlarged, which may underlie that more axons in the vehicle group lagged behind or they elongated with lower speed. It is also possible that EpoB treatment increased axonal branching.
We also measured axonal diameters at the site musculocutaneous nerve entering into biceps. Vehicle axonal diameters shifted to smaller range ( Fig. 7a and b, P < 0.001, z test), with 50% of them displayed diameters less than 3.08 lm. In contrast, axonal size of EpoB animals showed comparable distribution with normal ones, with half of them bigger than 4.31 lm in diameter. Electron microscopy confirmed the more comprehensive regeneration of EpoB-treated axons (Fig. 7c) . In vehicle-treated animals, a large portion of the nerve which originally bore axons was occupied by Schwann cells, due to lack of axonal regeneration. By contrast, EpoB-administrated nerve demonstrated more matured structures. Axons with bigger size were myelinated, giving the impression of healthy myelin sheath. They were also wrapped by basal lamina and surrounded by collagen fibers, and groups of unmyelinated axons were packed by Schwann cells as well. Meanwhile, a lot of mitochondria and microfilaments presented in axons.
Axons formed synaptic connection with distal muscle fibers
To reinnervate target muscles and control muscle contraction, the regenerated axons need to form synaptic connections with muscle fibers. Prolonged denervation leads to atrophy of postsynaptic structure (Sakuma et al., 2016) . The postsynaptic fold of neuromuscular junction, namely the motor endplate (MEP), is rich in acetylcholine receptors (AchRs). We stained the muscle fibers with a-BTX, which specifically binds to AchRs. While EpoB-treated MEP showed high similarity in the area distribution with those from normal muscles, the vehicle MEPs shrank to smaller size (vehicle and contralateral: P < 0.001, z test; vehicle and EpoB: P < 0.001, z test; Fig. 8a and  b) . In addition, the vehicle MEPs demonstrated vague outlines, suggesting decreased AchR density. Most of those MEPs with normal size and morphology were re-innervated by ChAT+ axons, and the reinnervations were more found in EpoB-treated muscles other than in vehicle ones (Fig. 8c) . Delayed or lack of re-innervation leaded to loss of AchR in vehicle MEPs.
Muscle atrophy were reduced by EpoB treatment
Prolonged denervation leads to muscle atrophy. We assessed the capability of EpoB treatment to prevent muscle atrophy. In normal muscle fibers, myocyte nucleus takes residence in the peripheral sarcoplasm. Moderate amount of fibroblast nuclei exists nearby ( Fig. 9a) . Chronic denervation leaded to severe shrinkage of sarcoplasm in vehicle biceps (vehicle and contralateral: P < 0.001, z test; vehicle and EpoB: P < 0.001, z test; Fig. 9b ). Meanwhile, a lot of fibroblast migrated in these two aspects, muscle loss and fibrosis, are two characteristics of muscle atrophy (Connor & McMahan, 1987) . By contrast, EpoB treatment prevented muscle loss, reflected by bigger size of muscle fibers, which was accompanied with alleviated fibroblast nuclei (Fig. 9a and b) . The diameter distribution of EpoB muscle fibers greatly resembled that of normal ones in biceps, which may underline high amount of reinnervation.
Discussion
Clinically, the introduction and improvement of microsurgical techniques have advanced the repair of brachial plexus injury. However, the root avulsion injury still presents a frustration to surgeons, because there is no applicable proximal nerve for repair and suturing the avulsed root to the spinal cord easily leads to CNS injury (Thatte et al., 2013) . In animal models, the use of fibrin glue sometimes obviated surgical suturing (de Vries et al., 2002) . Our team found that directly reattaching the root back to the ventrolateral pia surface of the spinal cord can also achieve physical reconnection between the two stumps (Chai et al., 1999; Gu et al., 2004; Su et al., 2013; Li et al., 2015) . Nevertheless, efficient axonal regeneration still requires exploring and integrity of other strategies to facilitate functional restoration.
In this study, we are reporting that after the ventral root avulsion+ re-implantation, the application of a FDA-approved microtubule-stabilizing drug, Epothilone B, promoted the axonal regeneration and reinnervation of distal muscles, which further enhanced the motor functional recovery. The blood-brain barrier permeable feature of EpoB makes it possible for systematical administration. Started from 0.25 h after intraperitoneal injection, EpoB was detected in both the spinal cord and brain, and the quantity persisted for at least 6 days (Ruschel et al., 2015) . The improved regeneration and recovery showing here were elicited by only two doses of intraperitoneal injection. We demonstrated that EpoB treatment not just promoted axonal regeneration, but attenuated the expression of inhibitory CSPG in TZ, which is in consistency with recent study in the spinal cord injury (Ruschel et al., 2015) . These dual effects and easy application of EpoB make it a promising therapeutic option (Tran & Silver, 2015) .
It is believed that both extracellular environment and intrinsic regrowth capability determine the regeneration outcome. After spinal root avulsion, the activated astrocytes in the glia limitans release inhibitory CSPG and the accumulation of CSPG can persist for months (Fraher, 2000; Silver & Miller, 2004; Cregg et al., 2014) . Indeed, our previous study showed that modulation of CSPG neuronal receptor protein tyrosine phosphatase-r enhanced the axonal regeneration and motor functional recovery (Li et al., 2015) . In fact, the known molecular impediments for CNS regeneration, such as CSPG, Nogo, myelin-associated glycoprotein (MAG), exert their suppressions via intracellular mechanisms, such as GSK-3b and Rho pathways, which in turn affect the dynamics and stability of microtubules (Sivasankaran et al., 2004; Zhou & Snider, 2005; Alabed et al., 2006; He & Jin, 2016; Niekerk et al., 2016) . In addition, recent study showed that autophagy induction promoted neurite outgrowth in cultured cortical neurons and axonal regeneration after spinal cord injury, via stabilizing microtubules (He et al., 2016) . Accumulating evidences suggested that microtubules might be a key controller for axonal regeneration. Consistently, we are reporting that intrinsic microtubule stabilization by EpoB promoted motor axons to navigate through the inhibitory CNS/PNS TZ. Meanwhile, in Alzheimer's disease and other tauopathies, the microtubule-stabilizing protein, tau, is altered (Brunden et al., 2009) . Microtubule stabilization by epothilone D (EpoD, another epothilone member with similar structure and binding site with EpoB) reduced axonal dysfunction, spine loss, neurotoxicity and cognitive deficits of the disease animals (Barten et al., 2012; Zhang et al., 2012; Penazzi et al., 2016) . These studies demonstrated that the fine regulation of microtubule dynamics was important for the normal function of neurons and for the nervous system.
Our study also demonstrated that, as the axons regenerated distally in the peripheral nerve, the difference of axon number between EpoB and vehicle animals was enlarged. This can be attributed to faster axonal elongation or increased axonal branching by EpoB. In vitro study using cortical neurons showed that EpoD only facilitated axonal sprouting, but did not speed up net growth (Brizuela et al., 2015) . Similarly, it was shown that taxol was not able to change the axon growth rate after a sciatic nerve crush in mice (Erturk et al., 2007) . Notably, we demonstrated that EpoB treatment actually speeded up axonal extension in the peripheral nerve. At the distal musculocutaneous nerve, the EpoB-treated axons displayed bigger size and more matured ultrastructure. After all, taxol and EpoB have distinct characteristics and different injury models (in vivo and in vitro, crush and transection and avulsion, CNS and PNS) affect the axonal regenerative performance differentially.
The high amount of motor axons in the CNS/PNS interface of EpoB-treated animals may underline the profound sprouting and branching in the spinal cord. When the axons regenerated into the peripheral nerve trunk, branching was reduced. It is reasonable that motoneurons use redundant sprouting as a strategy to find the right route. Once they successfully grew into the re-implanted root, axonal extension had higher priority over branching. Although we only re-implanted the C6 ventral root for potential regeneration and the Vehicle nerve exhibited higher proportion of small axons, compared with both contralateral and EpoB-treated nerve. Higher magnification images of the squared area were displayed at the bottom. (b) Distribution of axon diameters. Vehicle axons were shifted to smaller diameter range (n = 3 for contralateral, n = 5 for vehicle and EpoB, **P < 0.01, ***P < 0.001, z test). (c) Electron microscopy of distal musculocutaneous nerve. Schwann cells took up a lot more area than that of the axons in the vehicle-treated nerve. By contrast, EpoB-treated nerve showed more matured structure. Myelinated axons were enwrapped by basal laminin and surrounded by collagen fibers. Groups of unmyelinated axons were also packed by schwann cells. Plenty of mitochondria and neurofilaments were clearly pre- number of axons in the peripheral nerve did not achieve that of the normal nerve, EpoB treatment still greatly rescued muscle atrophy and showed high extent of reinnervation. Both the distribution of muscle fiber diameters and MEP areas showed high similarity to that of normal ones. This might underline great collateral branching in target muscle. One regenerated axon may reinnervate more muscle fibers than that of an intact axon.
Survival of injured motoneurons is a prerequisite for axon regeneration. In addition to the re-implantation of avulsed root, neurotrophic factors, such as brain-derived neurotrophic factors (BDNF) and glial cell-derived neurotrophic factors (GDNF) has also been proved to be beneficial for motoneuron survival (Chai et al., 1999; Wu et al., 2003; Chu & Wu, 2009 ). Schwann cells and muscle fibers demonstrated GDNF expression (Springer et al., 1994; Lie & Weis, 1998) . The neuroprotective effect of EpoB possibly resulted from an indirect outcome of promoted axonal regeneration. As EpoB treatment enabled more axons to grow into peripheral nerve and to access to distal sources of GDNF more easily, the progressive death of injured motoneurons was consequently reversed. Still, epothilone D has been demonstrated to rescue dopaminergic neurons in an experimental model of Parkinson's disease (Cartelli et al., 2013) . Therefore, whether EpoB can directly rescue the injured motoneurons after avulsion is still questionable. Meanwhile, the ChAT immunofluorescence intensity was generally higher in EpoBtreated animals at 9-week post-surgery, compared with that observed in the vehicle control animals. The downregulation of ChAT after axotomy might be attributed to that motoneurons shifted to another metabolism state, when survival has higher priority over motor control. This is in line with the upregulation of other set of surviving genes, such as BDNF, c-jun, and NGF receptor (Ernfors et al., 1989; Wu, 1996) . We still do not know whether EpoB as a microtubule stabilization drug can directly increase the synthesis and stability of ChAT. Nevertheless, by promoting axonal regeneration and reformation of neuromuscular junction, EpoB might indirectly facilitate the metabolism transition of motoneurons to a functional movement control state, when ChAT is highly demanded.
The possible side effects of EpoB treatment have leaded to some concerns. It was reported that high EpoB dosage (e.g. weekly EpoB injection for 4 weeks at 1 mg/kg body weight) caused loss of body mass (Chiorazzi et al., 2009 ). In addition, EpoB also impaired the nerve conduction, although it recovered to normal after the treatment stopped. The dosage adopted in the present study (0.75 mg/kg body weight, two doses at 1-and 15-day post injury) was relatively low. We did observe slight reduction of body weight in the first 3 weeks after surgery, but the avulsion injury also contributed to the reduction as showed in the vehicletreated animals. Both the EpoB and vehicle-treated animals started gaining weight after that. No other side effect was observed, and this is consistent with previous study (Ruschel et al., 2015) . Meanwhile, EpoD has been reported to induce dendritic simplification in cultured brain slice (Golovyashkina et al., 2015) . However, we observed more complex neurite structure in the ventral spinal cord of EpoB-treated animals, as reflected by ChAT immunostaining (Fig. 3c) , although the effect of EpoB on dendrites needs to be more carefully explored. Due to the poor solubility of EpoB in water, we used DMSO to dissolve the EpoB powder (see Methods and materials). Therefore, there existed < 1% (< 0.01 mL/kg body weight) DMSO in the injected EpoB solution. In a latest report, DMSO treatment (1% in drinking water, maintained for 34 days) increased spine density on neurons in a region-specific manner and displayed behavior influence in Alzheimer's disease model (Penazzi et al., 2017) . Our dosage is lower than that adopted in the paper. In addition, in our previous study and some others' work where DMSO was applied as vehicle control (daily injection of 500 lL 5% DMSO; Lang et al., 2014; Li et al., 2015) , no obvious impairment of the behavior and neuronal structure was observed. It remains to be investigated whether DMSO has any impact on the dynamics of microtubules and the outgrowth of axons and at what concentration range DMSO has such effect.
Taken together, our study showed that EpoB is a promising option in treating spinal root avulsion, although the detailed mechanisms still require more work. 
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